Literature DB >> 5130217

Pulmonary aspergillomata in a child treated with clotrimazole.

E G Evans, D A Watson, N R Matthews.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5130217      PMCID： PMC1799911          DOI： 10.1136/bmj.4.5787.599

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  2 in total

1.  [1st clinical experience with a new oral antimycotic in systemic mycoses].

Authors:  H Oberste-Lehn; I Baggesen; M Plempel
Journal:  Dtsch Med Wochenschr       Date:  1969-06-27       Impact factor: 0.628

2.  [Experimental findings on a new, orally active broad-spectrum antimycotic agent].

Authors:  M Plempel; K Bartmann; K H Büchel; E Regel
Journal:  Dtsch Med Wochenschr       Date:  1969-06-27       Impact factor: 0.628
  2 in total
  4 in total

Review 1.  Clotrimazole: a review of its antifungal activity and therapeutic efficacy.

Authors:  P R Sawyer; R N Brogden; R M Pinder; T M Speight
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies.

Authors:  M A Burgess; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

Review 3.  A guide to the recent literature on aspergillosis as caused by Aspergillus fumigatus, a fungus frequently found in self-heating organic matter.

Authors:  P B Marsh; P D Millner; J M Kla
Journal:  Mycopathologia       Date:  1979-11-30       Impact factor: 2.574

4.  Antifungal activity of tioconazole (UK-20,349), a new imidazole derivative.

Authors:  S Jevons; G E Gymer; K W Brammer; D A Cox; M R Leeming
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.